Even though the loss of SOCS1 did not correlate with increased MET or p21 expression as we had expected, our findings support the tumor suppressor function of SOCS1, and the oncogenic potential of MET and p21 in PCa. This evidence concerns the gene SOCS1 and posterior cortical atrophy.